9 assets in Irritable Bowel Syndrome

Therapeutic assets addressing Irritable Bowel Syndrome, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Rimegepant Irritable Bowel Syndrome	Mayo Clinic	P2	B (57)
B. Subtilis Irritable Bowel Syndrome	Jinling Hospital, China	Early P1	C (39)
Dead B. Subtilis Irritable Bowel Syndrome	Jinling Hospital, China	Early P1	C (39)
Alverine Irritable Bowel Syndrome	University of Pecs	N/A	D (30)
Bifidobacterium Irritable Bowel Syndrome	Rui Li	N/A	D (30)
Lactase Irritable Bowel Syndrome	University of Pecs	N/A	D (30)
Lactulose Irritable Bowel Syndrome	University Hospital, Rouen	N/A	D (30)
Pinaverium Irritable Bowel Syndrome	Rui Li	N/A	D (30)
Simethicone Irritable Bowel Syndrome	University of Pecs	N/A	D (30)